20-May-2026
Download PDF
Medicamen Biotech
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve the audited financial results (Standalone and Consolidated) for the quarter and year ended on March 31 2026 and for recommendation of Final Divided for FY 2025-26 on Equity Shares of the Company.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
